Biocompatibility of new peritoneal dialysis solutions: clinical experience.
about
Pathophysiology of the peritoneal membrane during peritoneal dialysis: the role of hyaluronanBimodal solutions or twice-daily icodextrin to enhance ultrafiltration in peritoneal dialysis patients.Neutral solution low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis.Regulation of complement C3 and C4 synthesis in human peritoneal mesothelial cells by peritoneal dialysis fluid.
P2860
Biocompatibility of new peritoneal dialysis solutions: clinical experience.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Biocompatibility of new peritoneal dialysis solutions: clinical experience.
@ast
Biocompatibility of new peritoneal dialysis solutions: clinical experience.
@en
Biocompatibility of new peritoneal dialysis solutions: clinical experience.
@nl
type
label
Biocompatibility of new peritoneal dialysis solutions: clinical experience.
@ast
Biocompatibility of new peritoneal dialysis solutions: clinical experience.
@en
Biocompatibility of new peritoneal dialysis solutions: clinical experience.
@nl
prefLabel
Biocompatibility of new peritoneal dialysis solutions: clinical experience.
@ast
Biocompatibility of new peritoneal dialysis solutions: clinical experience.
@en
Biocompatibility of new peritoneal dialysis solutions: clinical experience.
@nl
P1476
Biocompatibility of new peritoneal dialysis solutions: clinical experience
@en
P2093
A Tranaeus
E Garcia-Lopez
P304
P478
20 Suppl 5
P577
2000-01-01T00:00:00Z